Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)  
$26.25 0.20 (0.77%) as of 4:30 Tue 4/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 49,450,000
Market Cap: 1.30(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $25.5 - $46.6
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  623
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 119,323 119,323 201,796 291,198
Total Sell Value $3,656,226 $3,656,226 $6,836,738 $12,122,941
Total People Sold 1 1 15 17
Total Sell Transactions 3 3 36 59
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 781
  Page 2 of 32  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kronenfeld Mark A. Director   –       •      –    2023-06-08 4 AS $37.04 $555,600 D/D (15,000) 17,897 -19%     
   Kronenfeld Mark A. Director   –       •      –    2023-06-08 4 OE $29.90 $448,500 D/D 15,000 32,897     -
   Reinhardt Max President, Rest of World   •       –      –    2023-06-07 4 S $37.87 $41,614 D/D (1,099) 29,225 21%     
   Ellis Ronald J. Jr. Chief Strategy Officer   •       –      –    2023-06-07 4 S $37.87 $43,999 D/D (1,162) 30,909 21%     
   Riker Lauren Bullaro Senior Vice President, Finance   •       –      –    2023-06-07 4 S $37.87 $23,325 D/D (616) 19,053 21%     
   Stack David M CEO and Chairman   •       •      –    2023-06-07 4 S $37.87 $201,669 D/D (5,326) 153,781 21%     
   Winston Roy Chief Medical Officer   •       –      –    2023-06-07 4 S $37.87 $70,315 D/D (1,857) 41,356 21%     
   Reinhart Charles A. Iii Chief Financial Officer   •       –      –    2023-06-07 4 S $37.87 $51,913 D/D (1,371) 33,626 21%     
   Dunker Kristen Marie Chief Administrative Officer   •       –      –    2023-06-07 4 S $37.87 $51,383 D/D (1,357) 20,892 21%     
   Mcloughlin Dennis Chief Customer Officer   •       –      –    2023-06-07 4 S $37.87 $40,023 D/D (1,057) 38,115 21%     
   Gaugler Daryl Chief Operating Officer   •       –      –    2023-06-07 4 AS $37.87 $39,645 D/D (1,047) 21,539 -21%     
   Slonin Jonathan Chief Clinical Officer   •       –      –    2023-06-07 4 S $37.87 $18,554 D/D (490) 36,323 21%     
   Reinhardt Max President, Rest of World   •       –      –    2023-06-06 4 S $38.99 $41,097 D/D (1,054) 30,324 25%     
   Ellis Ronald J. Jr. Chief Strategy Officer   •       –      –    2023-06-06 4 S $38.99 $43,436 D/D (1,114) 32,071 25%     
   Riker Lauren Bullaro Senior Vice President, Finance   •       –      –    2023-06-06 4 S $38.99 $23,044 D/D (591) 19,669 25%     
   Molloy Anthony Chief Lgl & Compliance Officer   •       –      –    2023-06-06 4 AS $38.55 $174,285 D/D (4,521) 12,877 -25%     
   Stack David M CEO and Chairman   •       •      –    2023-06-06 4 S $38.99 $197,216 D/D (5,058) 159,107 25%     
   Winston Roy Chief Medical Officer   •       –      –    2023-06-06 4 S $38.99 $69,365 D/D (1,779) 43,213 25%     
   Reinhart Charles A. Iii Chief Financial Officer   •       –      –    2023-06-06 4 S $38.99 $48,193 D/D (1,236) 34,997 25%     
   Dunker Kristen Marie Chief Administrative Officer   •       –      –    2023-06-06 4 S $38.99 $50,727 D/D (1,301) 22,249 25%     
   Mcloughlin Dennis Chief Customer Officer   •       –      –    2023-06-06 4 S $38.99 $39,537 D/D (1,014) 39,172 25%     
   Gaugler Daryl Chief Operating Officer   •       –      –    2023-06-06 4 AS $38.99 $39,186 D/D (1,005) 22,586 -25%     
   Slonin Jonathan Chief Clinical Officer   •       –      –    2023-06-06 4 S $38.99 $18,365 D/D (471) 36,813 25%     
   Molloy Anthony Chief Lgl & Compliance Officer   •       –      –    2023-06-05 4 AS $38.28 $86,774 D/D (2,267) 17,398 -24%     
   Hastings Paul J Director   –       •      –    2023-06-05 4 S $38.34 $22,237 D/D (580) 6,599 24%     
  781 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 32
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us